EE200000732A - Karnitiini ja glutatiooni sisaldav kompositsioon glutatiooni imendumise suurendamiseks ning selle efektide sünergismiks - Google Patents

Karnitiini ja glutatiooni sisaldav kompositsioon glutatiooni imendumise suurendamiseks ning selle efektide sünergismiks

Info

Publication number
EE200000732A
EE200000732A EEP200000732A EEP200000732A EE200000732A EE 200000732 A EE200000732 A EE 200000732A EE P200000732 A EEP200000732 A EE P200000732A EE P200000732 A EEP200000732 A EE P200000732A EE 200000732 A EE200000732 A EE 200000732A
Authority
EE
Estonia
Prior art keywords
glutathione
synergizing
carnitine
effects
absorption
Prior art date
Application number
EEP200000732A
Other languages
English (en)
Estonian (et)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of EE200000732A publication Critical patent/EE200000732A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000732A 1999-04-16 2000-04-07 Karnitiini ja glutatiooni sisaldav kompositsioon glutatiooni imendumise suurendamiseks ning selle efektide sünergismiks EE200000732A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000230A IT1306130B1 (it) 1999-04-16 1999-04-16 Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
PCT/IT2000/000129 WO2000062773A1 (en) 1999-04-16 2000-04-07 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects

Publications (1)

Publication Number Publication Date
EE200000732A true EE200000732A (et) 2002-06-17

Family

ID=11406677

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000732A EE200000732A (et) 1999-04-16 2000-04-07 Karnitiini ja glutatiooni sisaldav kompositsioon glutatiooni imendumise suurendamiseks ning selle efektide sünergismiks

Country Status (25)

Country Link
US (1) US6306392B1 (xx)
EP (1) EP1087762B1 (xx)
JP (1) JP2002542191A (xx)
KR (1) KR20010071467A (xx)
CN (1) CN1300214A (xx)
AR (1) AR033325A1 (xx)
AT (1) ATE282409T1 (xx)
AU (1) AU774191B2 (xx)
BR (1) BR0006045A (xx)
CA (1) CA2334919C (xx)
DE (1) DE60015893T2 (xx)
EE (1) EE200000732A (xx)
ES (1) ES2232443T3 (xx)
HU (1) HU229272B1 (xx)
IL (1) IL139851A0 (xx)
IS (1) IS5740A (xx)
IT (1) IT1306130B1 (xx)
NO (1) NO20006285L (xx)
NZ (1) NZ509276A (xx)
PL (1) PL213130B1 (xx)
PT (1) PT1087762E (xx)
SK (1) SK18852000A3 (xx)
TN (1) TNSN00077A1 (xx)
TR (1) TR200003688T1 (xx)
WO (1) WO2000062773A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306147B1 (it) * 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
IT1316997B1 (it) 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
IT1316998B1 (it) 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
KR100528720B1 (ko) * 2002-08-29 2005-11-15 주식회사 메디넥스 중금속 제거용 특수 영양식품
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
WO2006074089A2 (en) 2004-12-30 2006-07-13 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
EP1871883A1 (en) 2005-03-02 2008-01-02 Metanomics GmbH Process for the production of fine chemicals
EP1928453B1 (en) 2005-08-17 2017-10-18 Hill's Pet Nutrition, Inc. Compositions and their use for the prevention and treatment of kidney disease
JP4831540B2 (ja) * 2005-08-26 2011-12-07 株式会社興人 経口催眠剤及び催眠性飲食物
JP2009107962A (ja) * 2007-10-29 2009-05-21 Asahi Breweries Ltd 酵母エキス含有組成物
EA019237B1 (ru) * 2008-11-11 2014-02-28 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Соединения, пригодные для лечения целлюлита
CN103535721B (zh) * 2013-09-27 2016-04-06 美国东方生物技术（香港）有限公司 提高人体内谷胱甘肽浓度的组合物及其制备方法和应用
CN103478718B (zh) * 2013-09-27 2015-10-28 美国东方生物技术（香港）有限公司 提高人体内谷胱甘肽浓度的功能食品及其制备方法
CN103750344B (zh) * 2014-01-25 2015-11-04 北京凯因科技股份有限公司 一种酵母谷胱甘肽营养配制品
IL261670B (en) * 2018-09-06 2019-06-30 Tudu Holdings Ltd Magnesium-containing formulation and uses thereof
JP7478517B2 (ja) * 2019-04-24 2024-05-07 三菱商事ライフサイエンス株式会社 脂質活性代謝改善組成物
KR102559814B1 (ko) * 2021-05-14 2023-07-26 가톨릭대학교 산학협력단 글루타치온을 유효성분으로 포함하는 신장질환 치료용 약학적 조성물
KR102535328B1 (ko) * 2022-10-18 2023-05-26 주식회사 청안오가닉스 흑후추 추출물을 함유하여 글루타치온의 체내 흡수율을 높인 건강기능 식품용 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
HU229272B1 (en) 2013-10-28
IS5740A (is) 2000-11-28
CN1300214A (zh) 2001-06-20
HUP0102501A3 (en) 2002-12-28
NZ509276A (en) 2002-09-27
HUP0102501A2 (hu) 2001-11-28
AU774191B2 (en) 2004-06-17
BR0006045A (pt) 2001-03-13
PL213130B1 (pl) 2013-01-31
TR200003688T1 (tr) 2001-06-21
ATE282409T1 (de) 2004-12-15
NO20006285D0 (no) 2000-12-11
JP2002542191A (ja) 2002-12-10
TNSN00077A1 (fr) 2002-05-30
DE60015893T2 (de) 2005-12-01
DE60015893D1 (de) 2004-12-23
AR033325A1 (es) 2003-12-17
ES2232443T3 (es) 2005-06-01
EP1087762A1 (en) 2001-04-04
KR20010071467A (ko) 2001-07-28
CA2334919A1 (en) 2000-10-26
IL139851A0 (en) 2002-02-10
IT1306130B1 (it) 2001-05-30
EP1087762B1 (en) 2004-11-17
WO2000062773A1 (en) 2000-10-26
AU4311700A (en) 2000-11-02
PT1087762E (pt) 2005-03-31
ITRM990230A1 (it) 2000-10-16
PL344790A1 (en) 2001-11-19
NO20006285L (no) 2001-02-12
CA2334919C (en) 2009-02-24
SK18852000A3 (sk) 2001-06-11
US6306392B1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
EE200000732A (et) Karnitiini ja glutatiooni sisaldav kompositsioon glutatiooni imendumise suurendamiseks ning selle efektide sünergismiks
NO20022751D0 (no) Basisforbindelse med forbedret proteininnhold
ID26936A (id) Komposisi herbisida konsentrat
DE69801193D1 (de) Verdikte Zusammensetzung enthaltend pyrogene Siliciumdioxid
EE200100113A (et) Atsetüül-L-karnitiini ning alfa-lipohapet sisaldav oksüdeerumisvastane kompositsioon
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
ATE407131T1 (de) Substituierte bipiperidine -zwischenverbindungen und deren derivate
NO20021116D0 (no) Ny sammensetning
IS6120A (is) Lyfjablanda
PT1165069E (pt) Composicao sinergistica antitumoral
ID26720A (id) Komposisi oral
ID29430A (id) Komposisi herbisida
DE69936027D1 (de) Kugelgewindespindel
NO20021115L (no) Ny sammensetning
DE69914914D1 (de) Feuchtigkeitshärtbare Zusammensetzung
NO20015849L (no) Blandinger inneholdende kreatin i suspensjon
DE69942892D1 (de) Gaserzeugende zusammensetzung
ATE260674T1 (de) Stabilisierte proteinzusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69910309D1 (de) Kugelumlaufspindel
DE69918751D1 (de) Fluorharzzusammensetzung
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
DE69813982D1 (de) Stabilisierte Zusammensetzungen zur perkutan Absorption